2Torzewski J,Torzewski M,Bowyer D E,et al.C-reactive protein frequently colocalizes with the terminal complement complex in the intima of early atherosclerotic lesions of human coronary arteries[J].Arterioscler Thromb Vase Biol,1998,18:1386-1392.
3Gensini G G.A more meaningful scoring system for determining the severity of coronary heart disease[J].Am J Cardiol,1983,51:606.
4Aukrust P,Ueland T,Lien E,et al.Cytokine network in congestiveheart failure secondary to ischemic or idiopathic dilated cardiomyopathy[J].Am J Cardiol,1999,83(3):367-382.
5Ballantyne C M,Hoogeveen R C.Role of lipid and lipoprotein profiles in risk assessment and therapy[J].Am Heart J,2003,146(2):227-233.
6Ingelsson E,Schaefer E J,Contois J H,et al.Clinical utility of different lipid measures for prediction of coronary heart disease in men and women[J].JAMA.2007,298(7):776-785.
7Phillips N R,Waters D,Havel R J.Plasma lipoproteins and progression of coronary artery disease evaluated by angiography andclinical events[J].Circulations,1993,88(6):2762-2770.
8Saito M,Ishimitsu T,Minami J,et al.Relations of plasma highsensitivity C-reactive protein to traditional cardiovas cular riskfactors[J].Atherosclerosis,2003,167:73-79.
9Pearsonl T,Mensah G A,Alexander R W,et al.Markers of inflammation and cardiovas cular disease:application to clinical and public health practice:a statement for healthcare professionals from the centers for diseas control and prevention and the ameriean heart association[J].Circulation,2003,107:499-511.
10Correale M,Brunetti N D,De Gennaro L,et al.Acute phase proteins in atherosclerosis (acute coronary syndrome)[J].Cardiovasc Hematol Agents Med Chem,2008,6(4):272-277.
